Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma
Status:
Completed
Trial end date:
2018-01-03
Target enrollment:
Participant gender:
Summary
Primary Objective:
To evaluate the effect of dupilumab, compared to placebo, on airway inflammation in
participants with persistent asthma.
Secondary Objective:
To assess the safety, tolerability, and immunogenicity of dupilumab compared to placebo.